Autophagy in liver diseases: time for translation?
M Allaire, PE Rautou, P Codogno, S Lotersztajn - Journal of Hepatology, 2019 - Elsevier
Autophagy is a self-eating catabolic pathway that contributes to liver homeostasis through its
role in energy balance and in the quality control of the cytoplasm, by removing misfolded …
role in energy balance and in the quality control of the cytoplasm, by removing misfolded …
[HTML][HTML] Autophagy in liver diseases
E Kouroumalis, A Voumvouraki… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Autophagy is the liver cell energy recycling system regulating a variety of homeostatic
mechanisms. Damaged organelles, lipids and proteins are degraded in the lysosomes and …
mechanisms. Damaged organelles, lipids and proteins are degraded in the lysosomes and …
[HTML][HTML] Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
C Verbaanderd, H Maes, MB Schaaf… - …, 2017 - ncbi.nlm.nih.gov
Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known 4-aminoquinoline
antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the …
antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the …
Autophagy-targeted calcium phosphate nanoparticles enable transarterial chemoembolization for enhanced cancer therapy
Transarterial chemoembolization (TACE) is commonly used for treating advanced
hepatocellular carcinoma (HCC). However, the instability of lipiodol-drug emulsion and the …
hepatocellular carcinoma (HCC). However, the instability of lipiodol-drug emulsion and the …
[HTML][HTML] Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK/mTOR dependent autophagy activation
L Gao, G Lv, R Li, W Liu, C Zong, F Ye, X Li, X Yang… - Cancer letters, 2019 - Elsevier
Metastasis and recurrence severely impact the treatment effect of hepatocellular carcinoma
(HCC). HCC complicated with cholestasis is more prone to recurrence and metastasis …
(HCC). HCC complicated with cholestasis is more prone to recurrence and metastasis …
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast …
LX Yan, YH Liu, JW Xiang, QN Wu… - International …, 2015 - spandidos-publications.com
We have previously shown that dysregulation of miR-21 functioned as an oncomiR in breast
cancer. The aim of the present study was to elucidate the mechanisms by which miR-21 …
cancer. The aim of the present study was to elucidate the mechanisms by which miR-21 …
Exosomal circTGFBR2 promotes hepatocellular carcinoma progression via enhancing ATG5 mediated protective autophagy
X Wang, FL Dong, YQ Wang, HL Wei, T Li, J Li - Cell death & disease, 2023 - nature.com
Exosomes contribute substantially to the communication between tumor cells and normal
cells. Benefiting from the stable structure, circular RNAs (circRNAs) are believed to serve an …
cells. Benefiting from the stable structure, circular RNAs (circRNAs) are believed to serve an …
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy
J Zhou, J Feng, Y Wu, HQ Dai, GZ Zhu… - … & Molecular Medicine, 2022 - nature.com
Transarterial chemoembolization (TACE) is the first-line treatment for unresectable
intermediate-stage hepatocellular carcinoma (HCC). It is of high clinical significance to …
intermediate-stage hepatocellular carcinoma (HCC). It is of high clinical significance to …
Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo
T Hu, P Li, Z Luo, X Chen, J Zhang… - Oncology …, 2016 - spandidos-publications.com
Recently, chloroquine (CQ) has been widely used to improve the efficacy of different
chemotherapy drugs to treat tumors. However, the effects of single treatment of CQ on liver …
chemotherapy drugs to treat tumors. However, the effects of single treatment of CQ on liver …
[HTML][HTML] Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma
J Sheng, H Qin, K Zhang, B Li… - American journal of cancer …, 2018 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a malignant tumor with poor prognosis. Surgical
resection is recommended for very early-stage and early-stage HCC, but HCC is still prone …
resection is recommended for very early-stage and early-stage HCC, but HCC is still prone …